Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Maggi

Showing results (451-460 of 469) with videos related to

Pageof 47
Sort By:
Frontiers in Endocrinology|November 25, 2022
The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohortRichard Ivell, Kee Heng, Katie Severn, et al.
The Journal of Sexual Medicine|June 18, 2015
The International Society for Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult MenJohn D Dean, Chris G McMahon, Andre T Guay, et al.
Mayo Clinic Proceedings|June 18, 2016
Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus ResolutionsAbraham Morgentaler, Michael Zitzmann, Abdulmaged M Traish, et al.
Andrology|May 22, 2020
Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patientsGiulia Rastrelli, Vincenza Di Stasi, Francesco Inglese, et al.
Clinical Endocrinology|June 2, 2018
Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: Prospective results from the EMASGiulia Rastrelli, Terence W O'Neill, Tomas Ahern, et al.
International Journal of Clinical Practice|October 25, 2016
Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME)Mario Maggi, Frederick C W Wu, Thomas H Jones, et al.
Andrology|December 10, 2021
Male reproductive system inflammation after healing from coronavirus disease 2019Simone Morselli, Arcangelo Sebastianelli, Andrea Liaci, et al.
The Journal of Clinical Endocrinology and Metabolism|May 23, 2015
Development of and Recovery from Secondary Hypogonadism in Aging Men: Prospective Results from the EMASGiulia Rastrelli, Emma L Carter, Tomas Ahern, et al.
The Journal of Sexual Medicine|November 26, 2009
Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS)Giovanni Corona, David M Lee, Gianni Forti, et al.
Human Reproduction (Oxford, England)|April 1, 2021
Reply: COVID-19: semen impairment may not be related to the virusMauro Gacci, Marco Coppi, Elisabetta Baldi, et al.
Pageof 47

Showing results (451-460 of 469) with videos related to

Sort By:
Pageof 47
Frontiers in Endocrinology|November 25, 2022
The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohortRichard Ivell, Kee Heng, Katie Severn, et al.
The Journal of Sexual Medicine|June 18, 2015
The International Society for Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult MenJohn D Dean, Chris G McMahon, Andre T Guay, et al.
Mayo Clinic Proceedings|June 18, 2016
Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus ResolutionsAbraham Morgentaler, Michael Zitzmann, Abdulmaged M Traish, et al.
Andrology|May 22, 2020
Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patientsGiulia Rastrelli, Vincenza Di Stasi, Francesco Inglese, et al.
Clinical Endocrinology|June 2, 2018
Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: Prospective results from the EMASGiulia Rastrelli, Terence W O'Neill, Tomas Ahern, et al.
International Journal of Clinical Practice|October 25, 2016
Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME)Mario Maggi, Frederick C W Wu, Thomas H Jones, et al.
Andrology|December 10, 2021
Male reproductive system inflammation after healing from coronavirus disease 2019Simone Morselli, Arcangelo Sebastianelli, Andrea Liaci, et al.
The Journal of Clinical Endocrinology and Metabolism|May 23, 2015
Development of and Recovery from Secondary Hypogonadism in Aging Men: Prospective Results from the EMASGiulia Rastrelli, Emma L Carter, Tomas Ahern, et al.
The Journal of Sexual Medicine|November 26, 2009
Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS)Giovanni Corona, David M Lee, Gianni Forti, et al.
Human Reproduction (Oxford, England)|April 1, 2021
Reply: COVID-19: semen impairment may not be related to the virusMauro Gacci, Marco Coppi, Elisabetta Baldi, et al.
Pageof 47